Predictive value of IL-35 and IL-17 in diagnosis of childhood asthma

References

• Ma Y, Liua X, Wei Z, Wang X, Xu D, Dai S, Li Y, Gao M, Ji C, Guo C, Zhang L, Wang X. The expression of a novel anti-inflammatory cytokine IL-35 and its possible significance in childhood asthma. Immunol Lett 2014;162:11–17.
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol 2015;16:45–56.
   PubMed Web of Science ®Google Scholar
• Yangzong Y, Shi Z, Nafstad P, Haheim LL, Luobu O, Bjertness E. The prevalence of childhood asthma in China: a systematic review. BMC Public Health 2012;12:860.
   PubMed Web of Science ®Google Scholar
• Chen C, Deng Y, Chen H, Wu X, Cheng S, Xu Y, Xiong W, Xie J. Decreased concentration of IL-35 in plasma of patients with asthma and COPD. Asian Pac J Allergy Immunol 2014;32:211–17.
   PubMed Web of Science ®Google Scholar
• Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 2003;3:405–12.
   PubMed Web of Science ®Google Scholar
• Green CE, Turne AM. The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD). Green and Turner Respiratory Research 2017;18:20.
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003;3:133–46.
   PubMed Web of Science ®Google Scholar
• Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008;8:523–32.
   PubMed Web of Science ®Google Scholar
• Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol 2012;13:722–8.
   PubMed Web of Science ®Google Scholar
• Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DAA. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010;11:1093–01.
   PubMed Web of Science ®Google Scholar
• Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007;37:3021–9.
   PubMed Web of Science ®Google Scholar
• Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007;450:566–9.
   PubMed Web of Science ®Google Scholar
• Huang CH, Loo EX, Kuo IC, Soh GH, Goh DL, Lee BW, Chua KY. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol 2011;187:462–71.
   PubMed Web of Science ®Google Scholar
• Tato CM, O’Shea J. Immunology: what does it mean to be just 17? Nature 2006;441:166–8.
   PubMed Web of Science ®Google Scholar
• Kolls JK. Interleukin-17 family members and inflammation. Immunity 2004; 21:467–76.
   PubMed Web of Science ®Google Scholar
• PèNe J, Chevalier S, Preisser L, Vénéreau E, Guilleux MH, Ghannam S, Molès JP, Danger Y, Ravon E, Lesaux S, Yssel H, Gascan H. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008;180:7423–30.
   PubMed Web of Science ®Google Scholar
• Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, Ceuppens JL. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006;7:135.
   PubMed Web of Science ®Google Scholar
• World Medical Association: Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects, The 59th WMA General Assembly, Seoul, South Korea; 2008.
   Google Scholar
• Global initiative of Asthma (GINA): Global strategy for asthma management and prevention. 2016.
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van Der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. ATS/ERS Task Force. Standardization of spirometry. Eur Respir J 2005;26:319–38.
   PubMed Web of Science ®Google Scholar
• England JM, Rowan RM, van Assendelft OW, Coulter WH, Groner W, Jones AR, Koepke JA, Lewis SM, Shinton NK, Thom R. Protocol for evaluation of automated blood cell counters. International Committee for Standardization in Haematology (ICSH). Clin Lab Haematol 1984;6:69–84.
   PubMedGoogle Scholar
• Westergren A. Studies of suspension stability of the blood in pulmonary tuberculosis. Am Rev Tuberc 1921;14:94–7.
   Google Scholar
• Humbert M. Pro-eosinophilic cytokines in asthma. Clin Exp Allergy 1996;26:123–7.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Lafontaine JS, Godard P, Michel FB. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033–9.
   PubMed Web of Science ®Google Scholar
• Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AM, Schwartz LB, Durham SR, Jeffery PK, Kay AB. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. Allergy Clin Immunol 1991;88:661–74.
   Google Scholar
• Pizzichini E, Pizzichini MM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic canonic protein in induced sputum compared with peripheral blood. Allergy Clin Immunol 1997;99:539–44.
   Google Scholar
• Bentley AM, Menz G, Storz C, Robinson DS, Bradley B, Jeffery PK, Durham SR, Kay AB. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness Am Rev Respir Dis 1992;146:500–6.
   PubMed Web of Science ®Google Scholar
• Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Björnsson E, Roomans GM, Boman G, Sevéus L, Venge P. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med 2000;162:2295–01.
   PubMed Web of Science ®Google Scholar
• Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G, Barkans J, Ying S, Kay AB. High affinity IgE receptor (FcɛRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med 1996;153:1931–7.
   PubMed Web of Science ®Google Scholar
• Ying S, Humbert M, Meng Q, Pfister R, Menz G, Gould HJ, Kay AB, Durham SR. Local expression of ɛ germline gene transcripts and RNA for the ɛ heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J Allergy Clin Immunol 2001;107:686–92.
   PubMed Web of Science ®Google Scholar
• Kovač K, Dodig S, Tješić-Drinković D, Raos M. Correlation between asthma severity and serum IgE in asthmatic children sensitized to dermatophagoides pteronyssinus. Arch Med Res. 2007;38:99–105.
   PubMed Web of Science ®Google Scholar
• Chandran CNM, Kiran GS, Babu KR, Buchineni M. Serum IgE levels as a marker of disease activity in childhood asthma: A cross sectional study. IAIM 2015;2:45–51.
   Google Scholar
• Buc M, Dzurilla M, Vrlik M, Bucova M. Immunopathogenesis of bronchial asthma. Arch Immunol Ther Exp (Warsz) 2009;57:331–44.
   PubMed Web of Science ®Google Scholar
• Satwani H, Rehman A, Ashraf S, Hassan A. Is serum total IgE levels a good predictor of allergies in children? J Pak Med Assoc 2009;59:698–02.
   PubMedGoogle Scholar
• Chesne J, Braza F, Mahay G, Brouard S, Aronica M, Magnan A. IL-17 in severe asthma where do we stand? Am J Respir Crit Care Med 2014;190:1094–01.
   PubMed Web of Science ®Google Scholar
• Al-Ramli W, Pr´Efontaine D, Chouiali F, Martin JG, Olivenstein R, LemièEre C, Hamid Q. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 2009;123:1185–7.
   PubMed Web of Science ®Google Scholar
• Irvin C, Zafar I, Good J, Rollins D, Christianson C, Gorska MM, Martin RJ, Alam R. Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. J Allergy Clin Immunol 2014;134:1175–86.
   PubMed Web of Science ®Google Scholar
• Agache I, Ciobanu C, Agache C, Anghel M. Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med 2010;104:1131–7.
   PubMed Web of Science ®Google Scholar
• Al-Kufaidy R, Vazquez-Tello A, BaHammam AS, Al-Muhsen S, Hamid Q, Halwani R. IL-17 enhances the migration of B cells during asthma by inducing CXCL13 chemokine production in structural lung cells. J Allergy Clin Immunol 2017; 139:696–9.
   PubMed Web of Science ®Google Scholar
• Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, Lam CWK. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001;125:177–83.
   PubMed Web of Science ®Google Scholar
• Wang W, Li P, Chen YF, Yang J. A potential immunopathogenic role for reduced IL-35 expression in allergic asthma. J Asthma 2015;52:763–71.
   PubMed Web of Science ®Google Scholar
• Yao-Yuan Z, Kong Z. Change of serum interleukin 35 concentration in asthma and its significance. J Sun Yat-Sen Univ 2012;33:398–401.
   Google Scholar